Here are the latest notable developments on infant formula from reputable sources:
-
U.S. FDA warnings and oversight: The FDA has continued to tighten oversight of infant formula facilities, including issuing warning letters to manufacturers to address safety concerns after past recalls and to prevent future shortages. This reflects ongoing efforts to strengthen manufacturing controls and prevent contamination in powdered infant formula. These actions aim to protect infants and reassure caregivers about product safety in the U.S. market.[1][5]
-
Global recalls and contamination concerns: Nestlé and other brands have faced large recalls and batch withdrawals due to contamination risks (e.g., cereulide toxin) across multiple countries, affecting hundreds of products and prompting consumer advisories to check batch numbers or discontinue use of affected lots. These recalls underscore the fragility of the global infant formula supply chain and the importance of robust quality controls.[2][4][8]
-
Notable recalls and investigations in 2025–2026: Several outlets reported new recalls and investigations linked to infant formula contamination or botulism concerns, including Brand ByHeart’s voluntary recall expansions in the U.S. and ongoing inquiries by health agencies in multiple regions. Public health authorities emphasize promptly removing affected products from circulation and notifying caregivers about safety steps.[3]
-
Regulatory context and guidance: Guidance and regulatory updates continue to evolve, with agencies like the FDA issuing draft guidelines and reinforcing current good manufacturing practices for infant formula production, emphasizing preventive controls and risk management. This indicates a trend toward more stringent requirements for formula makers internationally.[5]
-
Regional and ongoing coverage: Coverage across outlets in the Americas and Europe highlights that infant formula safety remains a high-priority public health issue, with recalls, batch-specific guidance, and consumer alerts continuing to appear as new information emerges. For parents, the practical takeaway is to verify batch numbers, heed recall notices, and consult health professionals if there are concerns about a specific product.[2][3]
If you’d like, I can narrow this to a specific region (e.g., United States, Europe, or Chile) and summarize the most relevant recent recalls and regulatory actions, or pull the very latest official statements from the FDA or local health authorities. I can also provide a concise, caregiver-friendly quick-reference checklist for identifying and handling recalled formula.
Citations:
- FDA warning letters and oversight actions.[1]
- Nestlé recalls and cereulide toxin concerns across countries.[4][8][2]
- ByHeart recall developments and health investigations.[3]
- FDA and regulatory guidance updates on infant formula safety.[5]
Sources
An outbreak of botulism linked to ByHeart baby formula has sickened at least 15 infants in 12 states, officials say. The company announced Tuesday that it is expanding its voluntary recall to include all of its baby formula products while the investigation continues. The Centers for Disease Control and Prevention is investigating more than a dozen cases of infant botulism tied to the formula brand ByHeart, prompting a voluntary recall of the product. Officials say there have been 13 cases...
www.cbsnews.cominfant formula contamination Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. infant formula contamination Blogs, Comments and Archive News on Economictimes.com
economictimes.indiatimes.comThe FDA is issuing warning letters to three infant formula manufacturers as part of the agency’s ongoing commitment to enhance regulatory oversight.
www.fda.govGet all of the latest breaking local and international news stories as they happen, with up to the minute updates and analysis, from Ireland's National Broadcaster
www.rte.ieInfant Formula
www.fda.govThe Food and Drug Administration sent new warning letters to three formula companies citing contamination concerns inside Reckitt/Mead Johnson, Perrigo and ByHeart facilities.
abcnews.go.com